Novartis | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Alcon AG USD 20M 0 2024-09
Almirall EUR 25.62M 489K 2024-06
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Autolus Therapeutics Ltd 130K 0 2024-09
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Fresenius EUR 563M 0 2024-09
Fresenius Medical Care EUR 293.41M 0 2024-12
Galapagos EUR 293.94M 0 2024-12
Genmab DKK 66M 0 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
GRIFOLS EUR 119.6M 0 2024-12
Hikma Pharmaceutical USD 40M 0 2024-06
J&J USD 3.12B 0 2024-12
Lonza CHF 72M 0 2024-12
Merck EUR 565M 0 2024-09
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Novo Nordisk 446M 0 2024-09
Orion EUR 92.2M 0 2024-12
Pfizer USD 480M 0 2024-12
Philips EUR 188M 5M 2024-12
Recordati EUR 26.14M 0 2024-09
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
UCB EUR 189.72 584M 2024-06



Novartis Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.